214 related articles for article (PubMed ID: 10442692)
1. Non steady state and steady state PKS Bayesian forecasting and vancomycin pharmacokinetics in ICU adult patients.
Polard E; Le Bouquin V; Le Corre P; Kérebel C; Trout H; Feuillu A; Le Verge R; Mallédant Y
Ther Drug Monit; 1999 Aug; 21(4):395-403. PubMed ID: 10442692
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a two-compartment Bayesian forecasting program for predicting vancomycin concentrations.
Rodvold KA; Pryka RD; Garrison M; Rotschafer JC
Ther Drug Monit; 1989; 11(3):269-75. PubMed ID: 2728085
[TBL] [Abstract][Full Text] [Related]
3. Bayesian forecasting of serum vancomycin concentrations with non-steady-state sampling strategies.
Rodvold KA; Rotschafer JC; Gilliland SS; Guay DR; Vance-Bryan K
Ther Drug Monit; 1994 Feb; 16(1):37-41. PubMed ID: 8160252
[TBL] [Abstract][Full Text] [Related]
4. Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia population.
Jarkowski A; Forrest A; Sweeney RP; Tan W; Segal BH; Almyroudis N; Wang ES; Wetzler M
J Oncol Pharm Pract; 2012 Mar; 18(1):91-6. PubMed ID: 21521799
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetic parameters of vancomycin in critically ill patients.
Llopis-Salvia P; Jiménez-Torres NV
J Clin Pharm Ther; 2006 Oct; 31(5):447-54. PubMed ID: 16958822
[TBL] [Abstract][Full Text] [Related]
6. Bayesian forecasting of serum gentamicin concentrations in intensive care patients.
Rodvold KA; Pryka RD; Kuehl PG; Blum RA; Donahue P
Clin Pharmacokinet; 1990 May; 18(5):409-18. PubMed ID: 2335046
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of vancomycin in Japanese adult patients.
Yasuhara M; Iga T; Zenda H; Okumura K; Oguma T; Yano Y; Hori R
Ther Drug Monit; 1998 Apr; 20(2):139-48. PubMed ID: 9558127
[TBL] [Abstract][Full Text] [Related]
8. Individualizing vancomycin dosage regimens: one- versus two-compartment Bayesian models.
Pryka RD; Rodvold KA; Garrison M; Rotschafer JC
Ther Drug Monit; 1989; 11(4):450-4. PubMed ID: 2741194
[TBL] [Abstract][Full Text] [Related]
9. Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.
Broeker A; Nardecchia M; Klinker KP; Derendorf H; Day RO; Marriott DJ; Carland JE; Stocker SL; Wicha SG
Clin Microbiol Infect; 2019 Oct; 25(10):1286.e1-1286.e7. PubMed ID: 30872102
[TBL] [Abstract][Full Text] [Related]
10. Vancomycin monitoring: one or two serum levels?
Andrés I; López R; Pou L; Piñol F; Pascual C
Ther Drug Monit; 1997 Dec; 19(6):614-9. PubMed ID: 9421100
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
Adane ED; Herald M; Koura F
Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
[TBL] [Abstract][Full Text] [Related]
12. Bayesian forecasting of serum vancomycin concentrations in neonates and infants.
Rodvold KA; Gentry CA; Plank GS; Kraus DM; Nickel E; Gross JR
Ther Drug Monit; 1995 Jun; 17(3):239-46. PubMed ID: 7624919
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetic modeling and clinical application of vancomycin in Chinese patients hospitalized in intensive care units.
Lin Z; Chen DY; Zhu YW; Jiang ZL; Cui K; Zhang S; Chen LH
Sci Rep; 2021 Jan; 11(1):2670. PubMed ID: 33514803
[TBL] [Abstract][Full Text] [Related]
14. Optimizing Predictive Performance of Bayesian Forecasting for Vancomycin Concentration in Intensive Care Patients.
Guo T; van Hest RM; Zwep LB; Roggeveen LF; Fleuren LM; Bosman RJ; van der Voort PHJ; Girbes ARJ; Mathot RAA; Elbers PWG; van Hasselt JGC
Pharm Res; 2020 Aug; 37(9):171. PubMed ID: 32830297
[TBL] [Abstract][Full Text] [Related]
15. Prediction of serum vancomycin concentrations using one-, two- and three-compartment models with implemented population pharmacokinetic parameters and with the Bayesian method.
Wu G; Furlanut M
J Pharm Pharmacol; 1998 Aug; 50(8):851-6. PubMed ID: 9751448
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.
Asbury WH; Darsey EH; Rose WB; Murphy JE; Buffington DE; Capers CC
Ann Pharmacother; 1993 Apr; 27(4):490-6. PubMed ID: 8477127
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the accuracy of a pharmacokinetic dosing program in predicting serum vancomycin concentrations in critically ill patients.
Aubron C; Corallo CE; Nunn MO; Dooley MJ; Cheng AC
Ann Pharmacother; 2011 Oct; 45(10):1193-8. PubMed ID: 21896920
[TBL] [Abstract][Full Text] [Related]
18. Pilot Study of a Bayesian Approach To Estimate Vancomycin Exposure in Obese Patients with Limited Pharmacokinetic Sampling.
Carreno JJ; Lomaestro B; Tietjan J; Lodise TP
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28289024
[TBL] [Abstract][Full Text] [Related]
19. Influence of Mechanical Ventilation on the Pharmacokinetics of Vancomycin Administered by Continuous Infusion in Critically Ill Patients.
Medellín-Garibay SE; Romano-Moreno S; Tejedor-Prado P; Rubio-Álvaro N; Rueda-Naharro A; Blasco-Navalpotro MA; García B; Barcia E
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893792
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a Bayesian method for predicting vancomycin dosing.
Burton ME; Gentle DL; Vasko MR
DICP; 1989 Apr; 23(4):294-300. PubMed ID: 2728513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
